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ABSTRACT
Objective: The study’s purpose has been to describe the characteristics of cases of tuberculosis treatment 
abandonment in patients who developed multidrug-resistant tuberculosis (MDR-TB). Methods: It is a 
descriptive study with a quantitative approach that was carried out in a tertiary referral institution for the 
treatment of MDR-TB, located in the Rio de Janeiro city. A structured instrument was used with information from 
forty medical records between August and December 2016. Data analysis was performed using SPSS software. 
Results: Considering the patients studied, 35% abandoned previous treatment of tuberculosis. Conclusion: It 
is necessary the early identification of patients who are at greater risk for treatment abandonment, as well as 
the creation of a model of assistance aimed at the profile of users who abandon treatment, with a participatory 
practice with educational groups that promote preventive actions, identifying and experimenting strategies for 
overcoming barriers linked to reality, in both individual and collective lives.
Descriptors: Tuberculosis resistant to multiple medications, drug therapy adherence, therapy.
RESUMO
Objetivos: Descrever as características dos casos de abandono do tratamento de tuberculose em pacientes que desenvolveram tuberculose 
multirresistente (TBMR). Métodos: Estudo descritivo de abordagem quantitativa, desenvolvido em uma instituição terciária de referência 
para tratamento de TBMR localizada na cidade do Rio de Janeiro. Foi utilizado instrumento estruturado com informações de quarenta 
prontuários entre os meses de agosto a dezembro de 2016. A análise dos dados foi realizada por meio do software SPSS. Resultados: 
Dos pacientes estudados, 35% abandonaram tratamento anterior de tuberculose. Conclusão e implicação para a prática: É necessária 
a identificação precoce de pacientes que apresentam maior risco para abandono do tratamento, bem como a criação de um modelo 
de assistência voltado ao perfil dos usuários que abandonam o tratamento, com uma prática participativa, com grupos educativos que 
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promovam ações preventivas, identificando e estudando estratégias para 
a superação de barreiras ligadas à realidade de vida individual e coletiva. 
Descritores: Tuberculose Resistente a Múltiplos Medicamentos, Adesão a 
Medicação, Terapêutica. 
RESUMEN
Objetivos: Describir las características de los casos de abandono del 
tratamiento de tuberculosis en pacientes que desarrollaron TBMR. 
Métodos: estudio descriptivo de abordaje cuantitativo, desarrollado en 
una institución terciaria de referencia para tratamiento de TBMR, ubicado 
en la ciudad de Río de Janeiro. Se utilizó instrumento estructurado con 
informaciones de cuarenta prontuarios entre los meses de agosto a 
diciembre de 2016. El análisis de los datos fue realizado a través del 
software SPSS. Resultados: de los pacientes estudiados, el 35% abandonó 
el tratamiento anterior de la tuberculosis. Conclusión e implicación 
para la práctica: es necesaria la identificación precoz de pacientes que 
presentan mayor riesgo para el abandono del tratamiento, así como la 
creación de un modelo de asistencia orientado al perfil de los usuarios 
que abandonan el tratamiento, con una práctica participativa, con 
grupos educativos Que promuevan acciones preventivas, identificando, 
estudiando estrategias para la superación de barreras ligadas a la realidad, 
de vida individual y colectiva.
Descriptores: Tuberculosis Resistente a Múltiples Medicamentos, 
Adhesión a Medicación, Terapéutica.
INTRODUCTION
One of the main concerns regarding tuberculosis is 
reducing treatment cessation rates. In Brazil, the dropout 
rate is high, it is around 17%, but in many regions, it reaches 
higher levels. This leads to non-disruption of the transmission 
chain, as people with tuberculosis (TB) who do not adhere 
to therapy remain ill and continue as a source of contagion. 
Furthermore, treatment withdrawal leads to drug resistance 
and relapse of the disease, which imposes difficulties on 
the patient’s healing process, increasing the time and cost 
of treatment.1,2,3
The abandonment of the treatment itself is described 
by the Health Ministry as the absence of the user for more 
than 30 consecutive days after the date due to return, at the 
national level, between the Federation Units of the country, 
the proportion of abandonment varied from 2.8 to 15.9% in 
2014.4 This rupture in adherence results in a marked impact on 
indicators of incidence, resistance to multiple drugs, diseases, 
associated diseases, and increased mortality rates.5 Causes 
known to be associated with discontinuation of treatment 
involve factors intrinsic to the user, such as the use of alcohol 
and other drugs, false impression of healing and discomfort 
caused by lack of food and extrinsic factors as a modality of 
applied treatment and operationalization of health services.6
Still, as a potent ingredient for the challenge of tuberculosis 
control, multidrug resistance emerges for treatment. The 
World Health Organization estimates that around 480,000 
people develop MDR-TB every year.7 In 2013, only 20% of 
these people received recommended treatment regimens.7
Considering those patients who are actually treated, 
only 10% can heal. It may also present more resistant forms 
(XDR-TB) and with the possibility of improbable cure and 
consequent death.8
Nevertheless, the growth in the number of such cases is 
causing worldwide concern, and this clinical form of multidrug 
resistance has been increasingly linked to the deficiency of 
health systems and is nowadays a major global challenge of 
TB control.9 The advent of antibiotics for the treatment of 
tuberculosis corresponds to a high advance in the fight against 
the disease. Nonetheless, since its first use, antibiotic therapy 
has been associated with the emergence of drug-resistant 
strains of Mycobacterium tuberculosis.10
XDR-TB is a major threat to public health. Its very 
existence is a reflection of the lack of control of TB and the 
lack of implementation of the measures recommended in 
the WHO’s Stop TB Strategy, which should minimize the 
emergence of drug resistance.8
The number of multidrug-resistant tuberculosis (MDR-TB) 
cases and extensively drug-resistant tuberculosis (XDR-TB) 
has increased significantly in the world.11 Recent data show 
that the number of MDR-TB cases has tripled between 2009 
and 2013 in MDR-TB accounted for 3.5% of all new cases 
of tuberculosis and 20.5% of all TB cases previously treated, 
whereas cases of XDR-TB accounted for 9% of all cases of 
MDR-TB reported in 100 countries.12
Given the aforementioned, the study’s goal was to analyze 
the occurrence of tuberculosis treatment abandonment and the 
subsequent complication for the development of Multidrug-
Resistant Tuberculosis in a tertiary referral institution for 
the treatment of Multiresistant Tuberculosis, located in the 
Rio de Janeiro city.
METHODS
It is a descriptive study with a quantitative approach. 
This research was performed by considering the information 
obtained in 40 patients’ medical records that were referred 
with MDR-TB, in the Tisiology Service of the Hospital 
Universitário Clementino Fraga Filho (HUCFF). HUCFF is 
a referral hospital for the treatment of multidrug-resistant 
tuberculosis, located on the campus of the Universidade Federal 
do Rio de Janeiro (UFRJ), which currently receives patients 
diagnosed with multidrug-resistant tuberculosis related to 
program areas 2.2. At the time of collection, 40 patients had 
been admitted to HUCFF for treatment of MDR-TB, and all 
records were used for data collection, since all met the criteria 
for inclusion of the study.
The study was carried out over the period from August 
to December 2016 and the data were obtained by analyzing 
the medical records.
The population was composed of patients belonging to 
Programmatic Area (PA) 2.2 who are referred to (HUCFF) for 
the treatment of MDR-TB. The PA 2.2 has the study hospital 
as a reference for the treatment of MDR-TB and covers 7 
neighborhoods, as follows: Praça da Bandeira, Tijuca, Alto 
da Boa Vista, Maracanã, Vila Isabel, Andaraí, Grajaú.
The sample was delimited according to the following 
inclusion criteria: patients diagnosed with MDR-TB, age 
group of 18 years old or older, and treated with a basic 
regimen recommended by the Programa Nacional de Controle 
da Tuberculose (PNCT) [National Tuberculosis Control 
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Program]. As exclusion criteria, the medical records of 
users who presented incomplete information and difficulty 
understanding were not eligible.
For data collection, a structured questionnaire was used 
for the socio-demographic evaluation where the variables 
investigated were: gender, skin color, age, schooling, TB form, 
HIV test result, HIV-AIDS co-infection, and presence of 
other comorbidities.
We also searched for data on the form of entry into the 
program, whether they were treatment-naive patients (new 
case) or whether they were previously treated for tuberculosis 
(returns). In addition to data research as the predominant 
clinical form of tuberculosis and follow-up with the Directly 
Observed Treatment Short (DOTS) strategy.
The data obtained were coded and typed in Microsoft 
Excel 2010 spreadsheet and analyzed with the support of the 
statistical package for the social sciences SPSS version 22.0. 
They were treated with descriptive statistics and presented 
in frequency tables, with absolute values (n) and percentages 
(%) for the categorical variables.
All the ethical care that govern researches with human 
beings were observed and respected, according to the 
Resolution No. 466/2012, and in the Normative No. 001/2013 
regulated by the National Health Council.
The study was approved by the Research Ethics Committee 
of the Escola de Enfermagem Anna Nery (EEAN) from the 
Universidade Federal do Rio de Janeiro (UFRJ), on May 31st, 
2016, having as protocol the Certificado de Apresentação 
para Apreciação Ética (CAAE) [Certificate of Presentation 
for Ethical Appraisal] No. 54091116.7.0000.5238. 
RESULTS
Table 1 shows that among the 40 patients investigated, 
67.5% were male and 32.5% female, with the majority being 
42.5% brown skin color. When the level of schooling was 
analyzed, 40% of the total number of patients studied had 
between 4 and 7 years of schooling and 42.5% between 8 and 
11 years of schooling. This time was also observed among 
those who have abandoned treatment. 
Table 1 - Clinic and sociodemographic profile of the MDR-TB 
bearing patients.
Variable
Notified 
Cases 
Abandonment 
Cases
n % n %
Gender
Male 27 67.5 10 71.4
Female 13 32.5 4 28.6
Skin color
White 12 30 5 35.7
Brown 17 42.5 4 28.6
Black 11 27.5 5 35.7
Age
0-20 years old 3 7.5 1 7.2
21-40 years old 21 52.5 6 42.9
41-60 years old 8 20 4 28.5
61 years old or more 8 20 3 21.4
Schooling
0-3 years 4 10 1 7.2
4-7 years 16 40 10 71.4
8-11 years 17 42.5 3 21.4
12 or more 3 7.5 0 0
Variable
Notified 
Cases 
Abandonment 
Cases
n % n %
Program 
entrance
New case 26 65 NA NA
Return 14 35 14 100
AIDS
Yes 9 22.5 0 0
No 31 77.5 14 100
DOTS
Yes 10 25 1 7.2
No 30 75 13 92.8
Tuberculosis 
form
Pulmonary 35 87.5 13 92.8
Extrapulmonary 5 12.5 1 7.2
* NA - No applicable.
The average age was 43.6 years old with the variation 
between 18 and 77 years old. Considering the 40 patients, 
35% have abandoned treatment. Of those, 10% dropped 
out more than six times. When analyzed the educational 
level of those who dropped out of treatment 71.4% had less 
than seven years of study and when analyzed the level of 
education of those who did not abandon treatment 40% had 
less than seven years of study. Of the patients who left the 
treatment only one had the extrapulmonary form. Observing 
the total number of patients investigated, 25% received the 
Directly Supervised Treatment. When the comorbidity data 
were analyzed, the most present comorbidity was HIV with 
22.5% of coinfected patients. The BAAR test was positive in 
82.5% of the patients and the Culture test was positive in 70% 
of the cases. Regarding the Antimicrobial Sensitivity Test, 
45% presented resistance to at least two drugs: rifampicin 
and isoniazid. 
DISCUSSION
There is a consensus in the current literature about 
associating the emergence of MDR-TB strains with failures 
in health services, especially regarding the appropriate 
treatment of reported cases, so leaving the natural chain of 
transmission of the bacillus flowing.7 Several studies also 
point to the low adherence to treatment and/or inadequate 
pharmacological treatment as important factors for the 
emergence of MDR-TB.9 In Brazil, in 2000, the dropout rate 
was considered high and was around 17% .4 In this study, 
the dropout rate was considered high when compared to 
stipulated levels of 5% by WHO.8
Of the 35% patients who had abandoned treatment 
previously, 10% dropped out more than six times. In Brazil, 
96% of the cases of resistance of the bacilli are of the acquired 
type, the infected patients present bilateral pulmonary 
cavitations in 65% of the cases, and HIV co-infection in 
7%. For the treatment of these cases, it is necessary to use 
injectable drugs and reserve drugs, with a duration of 18 to 24 
months, whose effectiveness is approximately 60%.13 Another 
important fact is that drug resistance is an important risk of 
failure to institute treatment.14
In developing countries, such as Brazil, serious social 
inequalities, increased poverty and poor income distribution, 
when associated with poor medical and health conditions 
and, moreover, the difficulty in accessing health services, 
lead to higher rates of infection with the microorganism, 
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worsening of the disease, high frequency of comorbidities, 
co-infection as HIV/TB, and the development of multiple 
drug-resistant strains. Given this aforesaid context, one of 
the most serious problems today is undoubtedly multidrug-
resistant tuberculosis (MDR-TB) and extensively resistant 
tuberculosis (XDR-TB).15
The multi-resistance issue in Brazil is also associated 
with non-compliance with the therapeutic scheme. This is 
a serious problem in the context of TB control actions, since 
patients who abandon TB treatment and/or irregular therapy 
favor the persistence of microorganism transmission in the 
community and drug resistance, then negatively impacting 
disease control.4,7,9
The predominance of tuberculosis in males, one of the 
findings of this research, is similar to that found in the 
literature, pointing out that the difference in TB involvement 
between the sexes may be due to several factors, such as 
economic, cultural and social factors related to exposure to 
the bacillus.2,16,17
Herein, 25% of the patients were black and 35% brown 
and corroborate with other studies that indicate that in Brazil, 
blacks and browns have lower schooling, lower wages, reside 
in peripheral neighborhoods of large cities and are excluded 
from various rights social policies. Consequently, it can be 
hypothesized that the health, disease and death process is 
socially constructed and demarcated by the territorial and 
social space that black and white men and women occupy 
in society.18,19
It is known that socio-cultural factors can make treatment 
difficult, such as low level of education, lack of knowledge 
about tuberculosis and non-acceptance of the disease, and 
the fact that some patients consider themselves cured before 
the effective cure since patients feel good.20
The rate of abandonment to tuberculosis treatment verified 
in the cases analyzed in this study was 35%. Studies conducted 
in Brazil show abandonment rates varying from 38% to 42%, 
and these rates are extremely high, since the Health Ministry 
recommends only 5% of abandonment as acceptable.7 It is 
considered as abandonment, the patient who, once initiated 
the treatment stopped attending the Health Unit for more 
than thirty consecutive days, after the date set for the return.21 
High rates of treatment abandonment were also found in 
other studies conducted in the country, showing the need 
to implement actions aimed at their prevention, especially 
in those groups that are at greater risk for abandonment.2,16
Discontinuation of tuberculosis treatment contributes to 
the maintenance of transmission since patients who do not 
stick to it or use chemotherapy for insufficient time and/or 
incorrectly remain the source of contamination, increasing 
relapse rates and drug resistance. These factors impede healing 
since they increase the time and cost of treatment.18,22
In developing countries, 80.0% of those infected are 
between 15 and 59 years of age, considered to be the one 
with the highest social productivity, with economic and 
social implications for the individual and his family.23,24 In 
this study, the most affected age group was from 21 to 40 years 
old (52.5%), the highest dropout rate in this range may be 
related to the lifestyle of this population, which normally uses 
alcoholic beverages and has irregular feeding times, factors 
that may contribute to the interruption of treatment, these 
results were confirmed in several studies.20,25,26,27
Twenty percent of the disease cases were found in the 
range above 61 years, confirming that the increase in life 
expectancy of the population has changed the age profile 
of tuberculosis cases, increasing its occurrence among the 
elderly.2,16,28 Pulmonary localization is the most common form 
of MDR-TB in the present study, where 87.5% of the patients 
who presented the disease were pulmonary.29,30,31
The Health Ministry estimates that in the general 
population, 80.0% of the TB cases present the pulmonary 
form.32 When analyzed the educational level of those who 
left treatment, 71.4% had less than seven years of study and 
when analyzed the educational level of those who did not 
abandon the treatment 40% had less than seven years of study, 
confirming with data from the literature where San Pedro 
(2013) in an ecological study, discusses that it is possible 
to verify that indicators related to income, schooling, and 
population density are associated with tuberculosis at different 
levels of spatial aggregation.
Several factors may hinder the treatment and cure of 
tuberculosis, such as socio-cultural factors, low level of 
schooling, lack of knowledge about and acceptance of the 
disease, mistaken perception of being cured before effective 
cure, patients feel better after the first 15 days of treatment. The 
shorter the educational time, the greater the need of the special 
attention of the health professionals to the patient in treatment 
in the promotion of orientations of easy understanding for 
the patient, thus avoiding the abandonment.
According to the Programa Nacional de Controle da 
Tuberculose (PNCT) [National Tuberculosis Control 
Program], a prevalence of 50 million infected, 100,000 new 
cases and 4,000 deaths are estimated annually for Brazil 
and an incidence rate of 37.2/100,000 inhabitants.33 The 
World Health Organization currently considers that TB 
occupies an important percentage of the use of resources 
in the health sector.8
Data from the State Department of Health of Rio de Janeiro 
State that in 2014, 155 multi-resistant cases occurred in the 
State capital.
In 2013, Brazil registered 503 cases of MDR-TB, while 
countries such as Bolivia recorded 72 cases, Argentina 116 
cases of the disease, Paraguay only 6 cases of MDR-TB and 
10 cases in Venezuela.4 In 2014 Chile recorded 15 cases of 
MDR-TB in its country, where 9 of the cases of MDR-TB with 
Chilean nationality, 5 Peruvian cases and 1 Colombian case.35
When analyzing the data of cases of MDR-TB in Brazil in 
relation to the Mercosul countries, it is possible to observe a 
higher prevalence of MDR-TB cases in Brazil. This scenario can 
be justified because of the problematic of access to treatment, 
which is hampered by the current treatment regimens, which 
are long-term, poorly tolerated and difficult to administer in 
the places where the majority of patients reside, reasons that 
hinder adherence and the success of treatment, and these 
are one of the crucial factors for abandonment.36 One way 
is to facilitate access to treatment and especially to Directly 
Observed Treatment, so that we could provide thousands of 
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lives in the next decades to be preserved. The decentralization 
of diagnosis and treatment to health centers in the periphery 
would also facilitate patient care and could contribute to an 
improvement in cure rates and a reduction in the chain of 
bacillus transmission.
Aiming to reduce treatment abandonment rates, it 
is a priority to know the factors associated with such 
abandonment, in order to reorient people in TB treatment 
to practices and health care.28 In Rio de Janeiro city, forms of 
multidrug resistance have been established and disseminated 
among the various population groups, favored by the growth 
of community densities, is related to local “pockets of poverty” 
with a large concentration of housing units, without access 
to ventilation and lighting, which facilitates the spread of 
respiratory diseases.13
The increase in the rate of abandonment of treatment, 
the deterioration of health services due to the decrease of 
investments in the sector are also problems faced in the Rio 
de Janeiro city.37,38
In Brazil, the scarcity of recent studies on the epidemiology 
of MDR-TB in the country makes difficult the process of 
showing the real situation the disease in territory based on its 
determining and conditioning factors, be they social, cultural 
or clinical-epidemiological.
CONCLUSIONS
It is clear that in the 21st century, many patients suffer 
and die due to TB, although the disease is curable, and the 
treatment is fully funded by the Sistema Único de Saúde (SUS) 
[Unified Health System]. Involving cultural, economic, social 
and ideological dimensions, this scenario is related to several 
factors that are not restricted only to health policies, a reason 
that makes it difficult to control the disease.
The study found that the early identification of patients 
who are at greater risk for treatment abandonment justifies 
a careful approach to be defined according to the conditions 
of each location. Adherence to treatment, correct diagnosis, 
and appropriate therapy are not only important to the health 
status of the patients but are a public health problem.
The study confirms the need of creating a model of 
assistance focused on the users’ profile who abandon 
treatment, by promoting a participative, collective practice 
with educational groups that promote preventive actions, 
identifying and studying strategies for overcoming barriers 
linked to the reality of life, individual and collective. Hence, 
it is expected that the results of this study may contribute 
to the improvement of health actions, providing subsidies 
for the teams to intensify educational and awareness actions 
about the need to follow the treatment until healing, then 
reducing cases of treatment abandonment, therefore, reducing 
cases of MDR-TB.
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